FOXN3 controls liver glucose metabolism by regulating gluconeogenic substrate selection

Santhosh Karanth, Bhagirath Chaurasia, Faith M. Bowman, Trevor S. Tippetts, William L. Holland, Scott A. Summers, Amnon Schlegel

Research output: Contribution to journalArticle

Abstract

The FOXN3 gene locus is associated with fasting blood glucose levels in non-diabetic human population genetic studies. The blood glucose-modifying variation within this gene regulates the abundance of both FOXN3 protein and transcript in primary human hepatocytes, with the hyperglycemia risk allele causing increases in both FOXN3 protein and transcript. Using transgenic and knock-out zebrafish models, we showed previously that FOXN3 is a transcriptional repressor that regulates fasting blood glucose by altering liver gene expression of MYC, a master transcriptional regulator of glucose utilization, and by modulating pancreatic α cell mass and function through an unknown mechanism. Since homozygous Foxn3 null mice die perinatally, and heterozygous carries of the null allele are smaller than wild-type siblings, we examine the metabolic effects of decreasing mouse liver Foxn3 expression in adult life, performing dynamic endocrine tests not feasible in adult zebrafish. Fasting glucose, glucagon, and insulin; and dynamic responses to glucose, insulin, pyruvate, glutamine, and glucagon were measured. Gluconeogenic and amino acid catabolic gene expression was examined in livers, as well. Knocking down liver Foxn3 expression via transduction with adeno-associated virus serotype 8 particles encoding a short hairpin RNA targeting Fonx3 decreases fasting glucose and increases Myc expression, without altering fasting glucagon or fasting insulin. Liver Foxn3 knock-down confers increases glucose tolerance, has no effect on insulin tolerance or response to glucagon challenge, blunts pyruvate and glutamine tolerance, and modulates expression of amino acid transporters and catabolic enzymes. We conclude that liver Foxn3 regulates substrate selection for gluconeogenesis.

Original languageEnglish (US)
Article numbere14238
JournalPhysiological Reports
Volume7
Issue number18
DOIs
StatePublished - Sep 1 2019
Externally publishedYes

Fingerprint

Fasting
Glucagon
Glucose
Liver
Insulin
Blood Glucose
Zebrafish
Glutamine
Pyruvic Acid
Alleles
Amino Acid Transport Systems
Gene Expression
Dependovirus
Gluconeogenesis
Medical Genetics
Population Genetics
Hyperglycemia
Small Interfering RNA
Genes
Hepatocytes

Keywords

  • FOXN3
  • glucose
  • glutamine
  • liver
  • mouse
  • MYC
  • pyruvate

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Karanth, S., Chaurasia, B., Bowman, F. M., Tippetts, T. S., Holland, W. L., Summers, S. A., & Schlegel, A. (2019). FOXN3 controls liver glucose metabolism by regulating gluconeogenic substrate selection. Physiological Reports, 7(18), [e14238]. https://doi.org/10.14814/phy2.14238

FOXN3 controls liver glucose metabolism by regulating gluconeogenic substrate selection. / Karanth, Santhosh; Chaurasia, Bhagirath; Bowman, Faith M.; Tippetts, Trevor S.; Holland, William L.; Summers, Scott A.; Schlegel, Amnon.

In: Physiological Reports, Vol. 7, No. 18, e14238, 01.09.2019.

Research output: Contribution to journalArticle

Karanth, S, Chaurasia, B, Bowman, FM, Tippetts, TS, Holland, WL, Summers, SA & Schlegel, A 2019, 'FOXN3 controls liver glucose metabolism by regulating gluconeogenic substrate selection', Physiological Reports, vol. 7, no. 18, e14238. https://doi.org/10.14814/phy2.14238
Karanth S, Chaurasia B, Bowman FM, Tippetts TS, Holland WL, Summers SA et al. FOXN3 controls liver glucose metabolism by regulating gluconeogenic substrate selection. Physiological Reports. 2019 Sep 1;7(18). e14238. https://doi.org/10.14814/phy2.14238
Karanth, Santhosh ; Chaurasia, Bhagirath ; Bowman, Faith M. ; Tippetts, Trevor S. ; Holland, William L. ; Summers, Scott A. ; Schlegel, Amnon. / FOXN3 controls liver glucose metabolism by regulating gluconeogenic substrate selection. In: Physiological Reports. 2019 ; Vol. 7, No. 18.
@article{47927e18c7e94043b9061f4a2c1dfff5,
title = "FOXN3 controls liver glucose metabolism by regulating gluconeogenic substrate selection",
abstract = "The FOXN3 gene locus is associated with fasting blood glucose levels in non-diabetic human population genetic studies. The blood glucose-modifying variation within this gene regulates the abundance of both FOXN3 protein and transcript in primary human hepatocytes, with the hyperglycemia risk allele causing increases in both FOXN3 protein and transcript. Using transgenic and knock-out zebrafish models, we showed previously that FOXN3 is a transcriptional repressor that regulates fasting blood glucose by altering liver gene expression of MYC, a master transcriptional regulator of glucose utilization, and by modulating pancreatic α cell mass and function through an unknown mechanism. Since homozygous Foxn3 null mice die perinatally, and heterozygous carries of the null allele are smaller than wild-type siblings, we examine the metabolic effects of decreasing mouse liver Foxn3 expression in adult life, performing dynamic endocrine tests not feasible in adult zebrafish. Fasting glucose, glucagon, and insulin; and dynamic responses to glucose, insulin, pyruvate, glutamine, and glucagon were measured. Gluconeogenic and amino acid catabolic gene expression was examined in livers, as well. Knocking down liver Foxn3 expression via transduction with adeno-associated virus serotype 8 particles encoding a short hairpin RNA targeting Fonx3 decreases fasting glucose and increases Myc expression, without altering fasting glucagon or fasting insulin. Liver Foxn3 knock-down confers increases glucose tolerance, has no effect on insulin tolerance or response to glucagon challenge, blunts pyruvate and glutamine tolerance, and modulates expression of amino acid transporters and catabolic enzymes. We conclude that liver Foxn3 regulates substrate selection for gluconeogenesis.",
keywords = "FOXN3, glucose, glutamine, liver, mouse, MYC, pyruvate",
author = "Santhosh Karanth and Bhagirath Chaurasia and Bowman, {Faith M.} and Tippetts, {Trevor S.} and Holland, {William L.} and Summers, {Scott A.} and Amnon Schlegel",
year = "2019",
month = "9",
day = "1",
doi = "10.14814/phy2.14238",
language = "English (US)",
volume = "7",
journal = "Physiological Reports",
issn = "2051-817X",
publisher = "John Wiley and Sons Inc.",
number = "18",

}

TY - JOUR

T1 - FOXN3 controls liver glucose metabolism by regulating gluconeogenic substrate selection

AU - Karanth, Santhosh

AU - Chaurasia, Bhagirath

AU - Bowman, Faith M.

AU - Tippetts, Trevor S.

AU - Holland, William L.

AU - Summers, Scott A.

AU - Schlegel, Amnon

PY - 2019/9/1

Y1 - 2019/9/1

N2 - The FOXN3 gene locus is associated with fasting blood glucose levels in non-diabetic human population genetic studies. The blood glucose-modifying variation within this gene regulates the abundance of both FOXN3 protein and transcript in primary human hepatocytes, with the hyperglycemia risk allele causing increases in both FOXN3 protein and transcript. Using transgenic and knock-out zebrafish models, we showed previously that FOXN3 is a transcriptional repressor that regulates fasting blood glucose by altering liver gene expression of MYC, a master transcriptional regulator of glucose utilization, and by modulating pancreatic α cell mass and function through an unknown mechanism. Since homozygous Foxn3 null mice die perinatally, and heterozygous carries of the null allele are smaller than wild-type siblings, we examine the metabolic effects of decreasing mouse liver Foxn3 expression in adult life, performing dynamic endocrine tests not feasible in adult zebrafish. Fasting glucose, glucagon, and insulin; and dynamic responses to glucose, insulin, pyruvate, glutamine, and glucagon were measured. Gluconeogenic and amino acid catabolic gene expression was examined in livers, as well. Knocking down liver Foxn3 expression via transduction with adeno-associated virus serotype 8 particles encoding a short hairpin RNA targeting Fonx3 decreases fasting glucose and increases Myc expression, without altering fasting glucagon or fasting insulin. Liver Foxn3 knock-down confers increases glucose tolerance, has no effect on insulin tolerance or response to glucagon challenge, blunts pyruvate and glutamine tolerance, and modulates expression of amino acid transporters and catabolic enzymes. We conclude that liver Foxn3 regulates substrate selection for gluconeogenesis.

AB - The FOXN3 gene locus is associated with fasting blood glucose levels in non-diabetic human population genetic studies. The blood glucose-modifying variation within this gene regulates the abundance of both FOXN3 protein and transcript in primary human hepatocytes, with the hyperglycemia risk allele causing increases in both FOXN3 protein and transcript. Using transgenic and knock-out zebrafish models, we showed previously that FOXN3 is a transcriptional repressor that regulates fasting blood glucose by altering liver gene expression of MYC, a master transcriptional regulator of glucose utilization, and by modulating pancreatic α cell mass and function through an unknown mechanism. Since homozygous Foxn3 null mice die perinatally, and heterozygous carries of the null allele are smaller than wild-type siblings, we examine the metabolic effects of decreasing mouse liver Foxn3 expression in adult life, performing dynamic endocrine tests not feasible in adult zebrafish. Fasting glucose, glucagon, and insulin; and dynamic responses to glucose, insulin, pyruvate, glutamine, and glucagon were measured. Gluconeogenic and amino acid catabolic gene expression was examined in livers, as well. Knocking down liver Foxn3 expression via transduction with adeno-associated virus serotype 8 particles encoding a short hairpin RNA targeting Fonx3 decreases fasting glucose and increases Myc expression, without altering fasting glucagon or fasting insulin. Liver Foxn3 knock-down confers increases glucose tolerance, has no effect on insulin tolerance or response to glucagon challenge, blunts pyruvate and glutamine tolerance, and modulates expression of amino acid transporters and catabolic enzymes. We conclude that liver Foxn3 regulates substrate selection for gluconeogenesis.

KW - FOXN3

KW - glucose

KW - glutamine

KW - liver

KW - mouse

KW - MYC

KW - pyruvate

UR - http://www.scopus.com/inward/record.url?scp=85072655088&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072655088&partnerID=8YFLogxK

U2 - 10.14814/phy2.14238

DO - 10.14814/phy2.14238

M3 - Article

C2 - 31552709

AN - SCOPUS:85072655088

VL - 7

JO - Physiological Reports

JF - Physiological Reports

SN - 2051-817X

IS - 18

M1 - e14238

ER -